Janssen Sciences Ireland UC
Quick facts
Phase 3 pipeline
- FTC/TDF FDC · Infectious Disease
FTC/TDF is a fixed-dose combination of two nucleoside reverse transcriptase inhibitors that block HIV reverse transcriptase to prevent viral replication.
Phase 1 pipeline
- Formulation M1
- Formulation M2
- Formulation M3
- Formulation N1
- Formulation N2
- Formulation N3
- Rilpivirine formulation G002
- Rilpivirine formulation G007
- Rilpivirine formulation G009-01
- Rilpivirine Oral Tablet
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Janssen Sciences Ireland UC
What is Janssen Sciences Ireland UC's pipeline?
Janssen Sciences Ireland UC has 1 drugs in Phase 3, 0 in Phase 2, 10 in Phase 1. Late-stage candidates include FTC/TDF FDC.
Related
- Sector hub: All tracked pharma companies